A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery.

PHASE2TerminatedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

March 3, 2023

Primary Completion Date

March 26, 2025

Study Completion Date

June 23, 2025

Conditions
Acute Kidney Injury Following Cardiac Surgery
Interventions
DRUG

TIN816

TIN816

OTHER

Placebo

Placebo

Trial Locations (37)

3000

Novartis Investigative Site, Leuven

3600

Novartis Investigative Site, Genk

4032

Novartis Investigative Site, Debrecen

7623

Novartis Investigative Site, Pécs

10002

Novartis Investigative Site, Taipei

15706

Novartis Investigative Site, Santiago de Compostela

27710

Duke Univ Medical Center, Durham

28006

Novartis Investigative Site, Madrid

35000

Novartis Investigative Site, Rennes

44093

Novartis Investigative Site, Nantes

45147

Novartis Investigative Site, Essen

50406

Novartis Investigative Site, Tartu

75013

Novartis Investigative Site, Paris

85054

Mayo Clinic Phoenix, Phoenix

86021

Novartis Investigative Site, Poitiers

92200

Novartis Investigative Site, Neuilly-sur-Seine

93053

Novartis Investigative Site, Regensburg

119074

Novartis Investigative Site, Singapore

226003

Novartis Investigative Site, Lucknow

380054

Novartis Investigative Site, Ahmedabad

C1118AAT

Novartis Investigative Site, CABA

C1181ACH

Novartis Investigative Site, CABA

C1428DCO

Novartis Investigative Site, Buenos Aires

05403 000

Novartis Investigative Site, São Paulo

40301-155

Novartis Investigative Site, Salvador

H1T 1C8

Novartis Investigative Site, Montreal

H2X 0A9

Novartis Investigative Site, Montreal

H4J 1C5

Novartis Investigative Site, Montreal

GIV 4G5

Novartis Investigative Site, Québec

708 52

Novartis Investigative Site, Ostrava

01307

Novartis Investigative Site, Dresden

04289

Novartis Investigative Site, Leipzig

H 1096

Novartis Investigative Site, Budapest

H-1083

Novartis Investigative Site, Budapest

LT-08661

Novartis Investigative Site, Vilnius

08907

Novartis Investigative Site, L'Hospitalet de Llobregat

08916

Novartis Investigative Site, Badalona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY